ArticleBMC microbiology2025
Geographic distribution and genetic diversity of Brucella melitensis from Yunnan province, China.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Spatiotemporal dynamics and serosurveillance landscape of brucellosis at the human-animal interface in the Chinese Southwest: A retrospective study.PLoS neglected tropical diseases · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Human brucellosis is a re-emerging disease in Yunnan, China, that poses serious threats to public health. However, the species/biovars, geographic distribution, and genetic diversity profile of circulating strains remain unclear. In this study, bacteriology procedures, AMOS-PCR, agglutination tests with anti-A and anti-M monospecific sera, and multiple-locus variable-number tandem-repeat analysis (MLVA) genotyping approaches were applied to investigate the genetic diversity profile of the strains. A total of 514 B. melitensis strains were isolated and identified from 2017 to 2023, of which 498 were in biovar (bv.) 3 and 16 were in bv. 1; the strains were distributed in 12 cities/prefectures and 67 counties. These data show that human B. melitensis infection has become a serious public health challenge. Moreover, 514 strains were sorted into three MLVA-11 clusters (I-III): those strains harboring 15 MLVA-11 genotypes, those strains belonging to the Eastern Mediterranean lineage, and those strains exhibiting high genetic diversity. MLVA-16 was used to divide 514 strains into eight (a-h) clades that contained 208 MLVA-16 genotypes (GTs), of which 96 shared GTs comprising 402 strains, with a cluster rate of 78.21%, suggesting that the disease was potentially dominated by a cluster epidemic; however, further genome sequence analysis is necessary to uncover the epidemic pattern of the disease. The remaining 112 GTs were unique (single strain), suggesting they were linked to sporadic cases rather than a cluster epidemic. A nationwide MLVA-16 comparison showed that 81 genotypes were shared by strains from the present study and strains from 29 other provinces, implying that strains from the nationally recognized B. melitensis genotypes were continuously spread. However, further genome-based analysis is necessary to identify the transmission chain and source of infection. Another MLVA-16 comparison with global datasets showed that the strains in this study had genotypes that were completely identical to strains from Asia (Afghanistan, Kazakhstan, Mongolia, Syria, Turkey, Saudi Arabia, Vietnam, Iraq and India) and Europe (Portugal, Spain, and Greece), indicating that these strains belonged to internationally recognized lineages. Further genome analysis is needed to identify the phylogenetic relationships of these strains. The present study describes a comprehensive scenario involving bio-typing and genetic diversity characteristics of B. melitensis strains, which can provide vital clues to tailor surveillance and control measures for human brucellosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.